Status:
COMPLETED
Preemptive Analgesia for Primary Dysmenorrhoea
Lead Sponsor:
Hanan Nabil
Conditions:
Primary Dysmenorrhea
Eligibility:
FEMALE
15-25 years
Phase:
PHASE2
PHASE3
Brief Summary
Preemptive analgesia before the release of pain mediators
Detailed Description
spasmodic dysmenorrhea is one of the most distressing symptoms in women. adolescents shows a usual absence from school . prostaglandin release is one of the most accepted theory responsible for spasmo...
Eligibility Criteria
Inclusion
- nulliparous ladies
- with regular menstrual cycle pattern
- those experienced history of dysmenorrhea (primary or spasmodic)
- patients able to sallow tables
Exclusion
- irregular cycles
- any associated local causes( pelvic infection, endometriosis, fibroid or others)
- patients with familial Mediterranean fever or other intermenstrual attacks of abdominal pain
- gastric or duodenal ulcers or gastritis
- other contraindications to non steroidal anti-inflammatory drugs
- patients with severe diminution of vision or color discrimination
- patients with any depressive or mood disorders
- patients receiving any hormonal treatment
Key Trial Info
Start Date :
August 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT03323671
Start Date
August 1 2017
End Date
December 1 2017
Last Update
December 19 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mansoura University
Al Mansurah, Egypt, 35516